We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

In Vitro Diagnostics Industry Welcomes Pathology Report

The British In Vitro Diagnostics Association has welcomes the publication of the report of the second phase of Lord Carter’s Independent Review of Pathology Services.
News

Champions Biotechnology Partners to Establish Agreements for Preclinical Evaluation of Oncology Drugs

Champions Biotechnology’s Biomerk Tumorgrafts™ will be utilized by the Centocor for the preclinical evaluation of certain therapeutic agents.
News

Abbott Exercises its Option to Acquire IBIS Biosciences, a Subsidiary of ISIS

The acquisition worth $215 million will expand Abbott's position in molecular diagnostics for infectious disease.
News

Confusing Risk Information may Lead to Poor Cancer Treatment Choices

Tools designed to help guide treatment decisions are too complex for most patients to understand, U-M study finds.
News

Study Sheds Light on Causes of HIV Dementia

Einstein researchers clarify how two major variants of HIV differ in their ability to cause neurologic complications.
News

DxS and Amgen Enter into Collaboration to Provide a K-RAS Companion Diagnostic for Vectibix® in the United States

Companies plan to work together to further facilitate the use of Vectibix® in metastatic colorectal cancer patients with wild-type K-RAS status.
News

Compugen and Merck Serono to Collaborate on Novel Peptide for the Treatment of Inflammatory Diseases

The agreement provides Merck Serono with an option to exclusively license CGEN 855 peptide for worldwide development and commercialization.
News

Overweight Women at Increased Risk of Advanced Breast Cancer

A study of over 280,000 women showed that postmenopausal obese women have advanced breast cancer at significantly higher rates than women of normal weight.
News

Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals

Roche to acquire all the outstanding shares of Memory Pharmaceuticals for approximately USD 50 million.
News

Lilly Completes Acquisition of ImClone Systems

The acquisition will broaden Lilly's portfolio of marketed cancer therapies and oncology pipeline with up to three targeted therapies in Phase III in 2009.
Advertisement